CoChat

Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males

Schopohl, J. · 1993 · Human Reproduction
Cited by 56

The DOI matches its Crossref record.

Abstract

In this study, pulsatile gonadotrophin releasing hormone (GnRH) therapy and gonadotrophin therapy were compared for male patients with idiopathic hypothalamic hypogonadism. Thirty-six patients, 19 with this condition, and 17 with Kallmann's syndrome, were included in the study. Their mean age was 21.1 ± 3.0 years (±SD). They were divided into two groups of similar age, number and testicular volume. Pulsatile GnRH therapy was started with 4 μg GnRH s.c. every 2 h using a portable pump and gonadotrophin therapy with weekly i.m. injections of 3 × 2500 IU human chorionic gonadotrophin (HCG). After 8–12 weeks of HCG treatment, 150 IU human menopausal gonadotrophin (HMG) 2–4 times weekly were added and the dose of HCG reduced if necessary. Testosterone concentrations increased significantly more (P < 0.03) in the gonadotrophin group than in the GnRH group (22.5 ± 8.1 versus 16.8 ± 5.5 nmol/l). The rise in oestradiol levels was also significantly higher (P < 0.001) in the gonadotrophin group than in the GnRH group (150 ± 70 versus 88 ± 59 pmol/l). Five patients developed gynaecomastia during gonadotrophin therapy. An increased testicular volume (TV) occurred more rapidly (P < 0.001) and was significantly more pronounced (P < 0.001) after GnRH therapy (ΔTV = 8.1 ± 2.0 ml) than with gonadotrophins (ΔTV = 4.8 ± 1.8 ml). Sperm counts were performed in 14 patients given GnRH and in 17 patients given gonadotrophins. Ten patients given GnRH had positive sperm counts, ranging from 1.5 to 14 × 106 spermatozoa/ml; eight of those given gonadotrophins also developed spermatogenesis (2–26 × 106/ml). The mean time period until spermatogenesis started was significantly shorter (P < 0.02) with GnRH than with gonadotrophins (12 ± 1.6 versus 20 ± 2.3 months). These results show how endocrine and exocrine testicular function can be normalized by both forms of therapy. However, gonadotrophin therapy has more side-effects. Testicular growth is more pronounced with GnRH, and this therapy also initiates spermatogenesis more rapidly than gonadotrophin therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/8.suppl_2.175

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 56

Metadata

Authors
Schopohl, J.
Venue
Human Reproduction
Published
1993-11-01
Volume
8
Issue
suppl 2
Pages
175-179
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2148959321
Cited by
56
References
0
FWCI
0.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males. https://app.cochat.ai/papers/10.1093/humrep/8.suppl_2.175
The paper
Schopohl, J. (1993). Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males. Human Reproduction. https://doi.org/10.1093/humrep/8.suppl_2.175

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.